MRI Enhancement in Stromal Tissue Surrounding Breast Tumors: Association with Recurrence Free Survival following Neoadjuvant Chemotherapy

MRI Enhancement in Stromal Tissue Surrounding Breast Tumors: Association with Recurrence Free Survival following Neoadjuvant Chemotherapy

Bibliographic Details
Main Authors:	Jones, Ella F., Sinha, Sumedha P., Newitt, David C., Klifa, Catherine, Kornak, John, Park, Catherine C., Hylton, Nola M.
Format:	Online
Language:	English
Published:	Public Library of Science 2013
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3646993/

Similar Items

Effect of Imaging Parameter Thresholds on MRI Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Subtypes
by: Lo, Wei-Ching, et al.
Published: (2016)

Agreement of Mammographic Measures of Volumetric Breast Density to MRI
by: Wang, Jeff, et al.
Published: (2013)

Multi-Site Clinical Evaluation of DW-MRI as a Treatment Response Metric for Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
by: Galbán, Craig J., et al.
Published: (2015)

A prognostic index for locoregional recurrence after neoadjuvant chemotherapy
by: Herrero-Vicent, C, et al.
Published: (2016)

Most-enhancing tumor volume by MRI radiomics predicts recurrence-free survival “early on” in neoadjuvant treatment of breast cancer
by: Karen Drukker, et al.
Published: (2018-04-01)

Correlation of post-neoadjuvant chemotherapy response on MRI with final histology in breast cancer patients
by: Mahatma, Anjum, et al.
Published: (2015)

Neoadjuvant Chemotherapy in Invasive Bladder Cancer
by: Oliver, R.T.D.
Published: (1991)

Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)
by: Esserman, Laura J., et al.
Published: (2011)

Neoadjuvant chemotherapy and trastuzumab versus neoadjuvant chemotherapy followed by post-operative trastuzumab for patients with HER2-positive breast cancer
by: Palmieri, Carlo, et al.
Published: (2015)

Neoadjuvant chemotherapy adaptation and serial MRI response monitoring in ER-positive HER2-negative breast cancer
by: Rigter, L S, et al.
Published: (2013)

Assessing vascular effects of adding bevacizumab to neoadjuvant chemotherapy in osteosarcoma using DCE-MRI
by: Guo, J, et al.
Published: (2015)

Background Parenchymal Enhancement on Preoperative Magnetic Resonance Imaging: Association With Recurrence-Free Survival in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy
by: Choi, Ji Soo, et al.
Published: (2016)

Denosumab Chemotherapy for Recurrent Giant-Cell Tumor of Bone: A Case Report of Neoadjuvant Use Enabling Complete Surgical Resection
by: Agarwal, Amit, et al.
Published: (2013)

Early Prediction and Evaluation of Breast Cancer Response to Neoadjuvant Chemotherapy Using Quantitative DCE-MRI1
by: Tudorica, Alina, et al.
Published: (2016)

Resection of colorectal liver metastases following neoadjuvant chemotherapy
by: Chiappa, A, et al.
Published: (2007)

Implanted markers prior to neoadjuvant chemotherapy: preliminary report
by: Allan for the Dartford Breast Care Team, DM
Published: (2000)

Histopathologic changes following neoadjuvant chemotherapy in various malignancies
by: Sethi, Divya, et al.
Published: (2012)

Influence of neoadjuvant chemotherapy on prognosis of patients with synovial sarcoma
by: Yanan Wu, et al.
Published: (2017-05-01)

Neoadjuvant chemotherapy for locally advanced cervical cancer
by: Iwata, Takashi, et al.
Published: (2016)

Breast Cancer–Related Lymphedema after Neoadjuvant Chemotherapy
by: Kim, Myungsoo, et al.
Published: (2015)

Radiological assessment of neoadjuvant chemotherapy in breast cancer
by: Ollivier, Liliane
Published: (2015)

Neoadjuvant chemotherapy in oral cancers: Selecting the right patients
by: Vishak, S., et al.
Published: (2015)

Nomogram for Predicting Breast Conservation after Neoadjuvant Chemotherapy
by: Kim, Min Kyoon, et al.
Published: (2015)

Neoadjuvant chemotherapy in pancreatic cancer: innovative, but still difficult
by: Boeck, S, et al.
Published: (2014)

Neoadjuvant chemotherapy and pathologic response: a retrospective cohort
by: de Andrade, Diocésio Alves Pinto, et al.
Published: (2013)

Body fatness during childhood and adolescence and breast density in young women: a prospective analysis
by: Bertrand, Kimberly A., et al.
Published: (2015)

Our experience in using magnetic resonance imaging (MRI) as an adjunct to mammography and ultrasound in assessing response to neoadjuvant chemotherapy
by: Dall, B, et al.
Published: (2002)

Meta-analysis of agreement between MRI and pathologic breast tumour size after neoadjuvant chemotherapy
by: Marinovich, M L, et al.
Published: (2013)

Diagnostic accuracy of MRI to evaluate tumour response and residual tumour size after neoadjuvant chemotherapy in breast cancer patients
by: Bouzón Alberto, et al.
Published: (2016-03-01)

Erratum to: Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI
by: Nathaniel M. Braman, et al.
Published: (2017-07-01)

Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI
by: Nathaniel M. Braman, et al.
Published: (2017-05-01)

MRI-based response patterns during neoadjuvant chemotherapy can predict pathological (complete) response in patients with breast cancer
by: Briete Goorts, et al.
Published: (2018-04-01)

Survival is associated with complete response on MRI after neoadjuvant chemotherapy in ER-positive HER2-negative breast cancer
by: Loo, Claudette E., et al.
Published: (2016)

Diagnostic accuracy of MRI to evaluate tumour response and residual tumour size after neoadjuvant chemotherapy in breast cancer patients
by: Bouzón, Alberto, et al.
Published: (2016)

Use of MRI to predict response following neoadjuvant chemotherapy for breast cancer: how accurately can it guide surgical choice?
by: Tan, Sue, et al.
Published: (2015)

Pretreatment Diffusion-Weighted MRI Can Predict the Response to Neoadjuvant Chemotherapy in Patients with Nasopharyngeal Carcinoma
by: Zhang, Guo-Yi, et al.
Published: (2015)

Prognostic Significance of a Complete Response on Breast MRI in Patients Who Received Neoadjuvant Chemotherapy According to the Molecular Subtype
by: Ko, Eun Sook, et al.
Published: (2015)

Increase in lesion enhancement on gadoxetic acid enhanced MRI is associated with complete response to neoadjuvant chemotherapy in colorectal liver metastases
by: Islam, S, et al.
Published: (2015)

Breast DCE-MRI Kinetic Heterogeneity Tumor Markers: Preliminary Associations With Neoadjuvant Chemotherapy Response1
by: Ashraf, Ahmed, et al.
Published: (2015)

Treatment Response Evaluation of Breast Cancer after Neoadjuvant Chemotherapy and Usefulness of the Imaging Parameters of MRI and PET/CT
by: An, Yeong Yi, et al.
Published: (2015)